Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Neisseria gonorrhoeae
100%
Infection
76%
Infectious Disease
73%
Minimum Inhibitory Concentration
57%
Neisseria
49%
Prevalence
38%
Human immunodeficiency virus
37%
Antibiotic Resistance
33%
In Vitro
29%
Antibiotic Sensitivity
28%
Galleria mellonella
24%
Chlamydia Trachomatis
22%
Mycoplasma genitalium
14%
Whole Genome Sequencing
13%
Antimicrobial Agent
12%
Chlamydiae
11%
Susceptibility
11%
Arm
9%
Human Immunodeficiency Virus Infection
9%
Klebsiella pneumoniae
8%
Monkeypox Virus
8%
Ribonucleic Acid
7%
Evolution
7%
Streptococcus
6%
Agar Plate
5%
Blood Plasma
5%
ELISA
5%
Medicine and Dentistry
Men Who Have Sex with Men
60%
Human immunodeficiency virus
50%
Pre-Exposure Prophylaxis
43%
Sexually Transmitted Disease
38%
Neisseria gonorrhoeae
28%
Infection
28%
Chlamydia Trachomatis
27%
Antibiotic Resistance
26%
Gonorrhea
20%
Prevalence
17%
Chlamydiae
13%
Mycoplasma genitalium
13%
Quinolone Derivative
12%
Macrolide
11%
Antiinfective Agent
9%
Urine Sampling
9%
Lymphogranuloma Venereum
9%
Cross Sectional Study
8%
Vagina Ring
8%
Monkeypox
8%
Transgender
8%
Monkeypox Virus
8%
Syphilis
7%
Sexually Transmitted Infection
6%
Doxycycline
5%
Ethinylestradiol Plus Etonogestrel
5%
Side Effect
5%
Systematic Review
5%
Pharmacology, Toxicology and Pharmaceutical Science
Neisseria gonorrhoeae
30%
Macrolide
24%
Prevalence
23%
HIV
23%
Infection
22%
Mycoplasma genitalium
21%
Quinolone Derivative
20%
Antibiotic Resistance
19%
Gonorrhea
19%
Antiinfective Agent
15%
Azithromycin
12%
Sexually Transmitted Disease
12%
Ethinylestradiol Plus Etonogestrel
10%
Chlamydia Trachomatis
9%
Ceftriaxone
8%
Galleria mellonella
8%
Doxycycline
7%
Lactobacillus
6%
Randomized Controlled Trial
6%
Zoliflodacin
5%
Ciprofloxacin
5%
Dysbiosis
5%